Publications by authors named "A K Waljee"
Background: Little is known about the determinants of disease progression among African patients with chronic HBV infection.
Methods: We used machine-learning models with longitudinal data to establish predictive algorithms in a well-characterized cohort of Ethiopian HBV-infected patients without baseline liver fibrosis. Disease progression was defined as an increase in liver stiffness to >7.
Article Synopsis
- The study examines how patient activation and self-efficacy impact the daily lives of individuals with inflammatory bowel disease (IBD).
- Researchers surveyed 132 IBD patients using various assessment tools and found that both higher patient activation and self-efficacy correlate with a lower burden of IBD.
- The results suggest that self-efficacy plays a significant role in mediating the relationship between patient activation and the effects of IBD on patients' daily lives.
Background: Biosimilars are highly similar, but not identical, versions of originator biologic medications. Switching patients to biosimilars presents an opportunity to mitigate rising drug costs and expand patient access to important biologic therapies. However, decreased patient acceptance and adherence to biosimilar medications have been reported, which can lead to loss of treatment response, adverse reactions, and inefficient resource utilization.
View Article and Find Full Text PDFHealth Data Sciences and Cardiovascular Disease in Africa: Needs and the Way Forward.
Curr Atheroscler Rep
November 2024
Purpose Of Review: The rising burden of cardiovascular disease (CVD) in Africa is of great concern. Health data sciences is a rapidly developing field which has the potential to improve health outcomes, especially in low-middle income countries with burdened healthcare systems. We aim to explore the current CVD landscape in Africa, highlighting the importance of health data sciences in the region and identifying potential opportunities for application and growth by leveraging health data sciences to improve CVD outcomes.
View Article and Find Full Text PDFBackground And Aims: Sphingosine 1-phosphate receptor modulators (S1PRMs) are an effective treatment for ulcerative colitis (UC). This review summarizes all available randomized trial data on the efficacy and safety of S1PRM therapy.
Methods: Multiple publication databases were systematically searched for randomized control trials (RCTs) of adults with moderate to severe UC treated with S1PRMs.